Cargando…
Therapeutic Perspective on Tardive Syndrome with Special Reference to Deep Brain Stimulation
Tardive syndrome (TDS) is a potentially permanent and irreversible hyperkinetic movement disorder caused by exposure to dopamine receptor blocking agents. Guidelines published by the American Academy of Neurology recommend pharmacological first-line treatment for TDS with clonazepam (level B), ginkg...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5183634/ https://www.ncbi.nlm.nih.gov/pubmed/28082923 http://dx.doi.org/10.3389/fpsyt.2016.00207 |